CHU Estaing Service d'hématologie

Clermont-Ferrand 63003

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myelomonocytic Leukemia, MDS, Mantle Cell Lymphoma, Myelodysplastic Syndromes, Non-Hodgkin's Lymphoma, RAEB

Studies at this site

• Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts — Completed
• A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL). — Stopped early